DOOREME INC. – Trademark Portfolio

Entity Type: 03

DOOREME INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DOOREME. The owner is based in ATLANTA, GA.

3475 OAK VALLEY ROAD #1730

ATLANTA, GA 30326

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DOOREME
DOOREME
Registered 2015
DOOREME
DOOREME
Cancelled 2008
DOOREME
DOOREME
Registered 2008

Trademark Classifications

DOOREME INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does DOOREME INC. have?

DOOREME INC. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does DOOREME INC. file in?

DOOREME INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.

What are DOOREME INC.'s most well-known trademarks?

DOOREME INC.'s registered trademark portfolio includes well-known marks such as DOOREME. These are among 2 currently registered trademarks in the portfolio.

What is DOOREME INC.'s trademark registration success rate?

DOOREME INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.